Anti-VEGF intervention in neovascular AMD: benefits and risks restated as natural frequencies (2019)

First Author: Clearkin L
Attributed to:  MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjophth-2018-000257

PubMed Identifier: 31276032

Publication URI: http://europepmc.org/abstract/MED/31276032

Type: Journal Article/Review

Parent Publication: BMJ Open Ophthalmology

Issue: 1

ISSN: 2397-3269